X-linked agammaglobulinemia (XLA) is the prototype of primary humoral immunodeficiencies. Long-term follow-up studies regarding disease-related complications and outcome are scarce.
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality / Lougaris, V., Soresina, A., Baronio, M., Montin, D., Martino, S., Signa, S., Volpi, S., Zecca, M., Marinoni, M., Baselli, L.A., Dellepiane, R.M., Carrabba, M., Fabio, G., Putti, M.C., Cinetto, F., Lunardi, C., Gazzurelli, L., Benvenuto, A., Bertolini, P., Conti, F., et al.. - In: THE JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY. - ISSN 1097-6825. - STAMPA. - (2020), pp. 1-9. [10.1016/j.jaci.2020.03.001]
Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality
Conti, Francesca;Ricci, Silvia;Azzari, Chiara;Pignata, Claudio;
2020
Abstract
X-linked agammaglobulinemia (XLA) is the prototype of primary humoral immunodeficiencies. Long-term follow-up studies regarding disease-related complications and outcome are scarce.
| File | Dimensione | Formato | |
|---|---|---|---|
|
2020 Long-term follow-up of 168 patients with X-linked agammaglobulinemia reveals increased morbidity and mortality.pdf
Accesso chiuso
Tipologia:
Pdf editoriale (Version of record)
Licenza:
Tutti i diritti riservati
Dimensione
722.87 kB
Formato
Adobe PDF
|
722.87 kB | Adobe PDF | Richiedi una copia |
I documenti in FLORE sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.
